Log in to save to my catalogue

The Pharmacological Options in the Treatment of Eating Disorders

The Pharmacological Options in the Treatment of Eating Disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3727200

The Pharmacological Options in the Treatment of Eating Disorders

About this item

Full title

The Pharmacological Options in the Treatment of Eating Disorders

Publisher

Egypt: Hindawi Publishing Corporation

Journal title

ISRN pharmacology, 2013, Vol.2013, p.352865-5

Language

English

Formats

Publication information

Publisher

Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

The eating disorders (DCA) are complex systemic diseases with high social impact, which tend to become chronic with significant medical and psychiatric comorbidities. The literature data showed that there is good evidence to suggest the use of SSRIs, particularly at high doses of fluoxetine, in the treatment of BN reducing both the crisis of binge...

Alternative Titles

Full title

The Pharmacological Options in the Treatment of Eating Disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3727200

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3727200

Other Identifiers

ISSN

2090-5165,2090-5173

E-ISSN

2090-5173

DOI

10.1155/2013/352865

How to access this item